{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T22:33:42Z","timestamp":1789252422172,"version":"build-2803163510"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T00:00:00Z","timestamp":1773619200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005881","name":"Ministry of Culture and Innovation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005881","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011903","name":"Richter Gedeon Talentum Alap\u00edtv\u00e1ny","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011903","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012550","name":"Nemzeti Kutat\u00e1si, Fejleszt\u00e9si \u00e9s Innovaci\u00f3s Alap","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012550","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.ejps.2026.107510","type":"journal-article","created":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T16:47:10Z","timestamp":1773938830000},"page":"107510","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["In Vitro Investigation of Tapinarof-Loaded Nanogels in an Imiquimod-induced HaCaT\u2013THP-1 Co-Culture Model"],"prefix":"10.1016","volume":"221","author":[{"given":"Barbara","family":"Balogh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1gnes","family":"Klus\u00f3czki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1gota","family":"Pet\u0151","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e1lma","family":"Feh\u00e9r","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zolt\u00e1n","family":"Ujhelyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judit","family":"V\u00e1radi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ildik\u00f3","family":"B\u00e1cskay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2026.107510_bib0001","unstructured":"A Phase 3 Study of Tapinarof for the Treatment of Plaque Psoriasis in Pediatric Subjects, 2021."},{"key":"10.1016\/j.ejps.2026.107510_bib0002","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3390\/jfb14010019","article-title":"Nanoscale Topical Pharmacotherapy in Management of Psoriasis: Contemporary Research and Scope","volume":"14","author":"Ahmad","year":"2022","journal-title":"J. Funct. Biomater."},{"key":"10.1016\/j.ejps.2026.107510_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.122938","article-title":"An overview of topical lipid-based and polymer-based nanocarriers for treatment of psoriasis","volume":"638","author":"Aziz Hazari","year":"2023","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2026.107510_bib0004","doi-asserted-by":"crossref","first-page":"731","DOI":"10.3390\/pharmaceutics17060731","article-title":"Tapinarof Nanogels as a Promising Therapeutic Approach","volume":"17","author":"Balogh","year":"2025","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejps.2026.107510_bib0005","doi-asserted-by":"crossref","first-page":"675","DOI":"10.3390\/gels10110675","article-title":"Formulation and Evaluation of Different Nanogels of Tapinarof for Treatment of Psoriasis","volume":"10","author":"Balogh","year":"2024","journal-title":"Gels"},{"key":"10.1016\/j.ejps.2026.107510_bib0006","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.jaad.2020.10.085","article-title":"Tapinarof in the treatment of psoriasis: A review of the unique mechanism of action of a novel therapeutic aryl hydrocarbon receptor\u2013modulating agent","volume":"84","author":"Bissonnette","year":"2021","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.ejps.2026.107510_bib0007","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1208\/s12249-021-02057-z","article-title":"Recent Advancement in Topical Nanocarriers for the Treatment of Psoriasis","volume":"22","author":"Biswasroy","year":"2021","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ejps.2026.107510_bib0008","doi-asserted-by":"crossref","first-page":"S183","DOI":"10.1016\/j.jid.2023.03.1077","article-title":"1065 The topical AhR agonist tapinarof has broad in vivo immunosuppressive and immunomodulatory effects in human skin grafted mice","volume":"143","author":"Brito","year":"2023","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.ejps.2026.107510_bib0009","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jdermsci.2023.01.010","article-title":"Benvitimod inhibits MCM6-meditated proliferation of keratinocytes by regulating the JAK\/STAT3 pathway","volume":"109","author":"Cai","year":"2023","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.ejps.2026.107510_bib0010","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.intimp.2014.08.002","article-title":"THP-1 cell line: An in vitro cell model for immune modulation approach","volume":"23","author":"Chanput","year":"2014","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.ejps.2026.107510_bib0011","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.3390\/ijms26041618","article-title":"The Aryl Hydrocarbon Receptor (AHR): Peacekeeper of the Skin","volume":"26","author":"Dawe","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejps.2026.107510_bib0012","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1074\/mcp.M113.030916","article-title":"Rapid Temporal Dynamics of Transcription, Protein Synthesis, and Secretion during Macrophage Activation","volume":"13","author":"Eichelbaum","year":"2014","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.ejps.2026.107510_bib0013","author":"Eskes","year":"2019","journal-title":"The HaCaT\/THP-1 Cocultured Activation Test (COCAT) for skin sensitization: a study of intra-lab reproducibility and predictivity"},{"key":"10.1016\/j.ejps.2026.107510_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.123864","article-title":"Nanogels: Smart tools to enlarge the therapeutic window of gene therapy","volume":"653","author":"Espuche","year":"2024","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2026.107510_bib0015","doi-asserted-by":"crossref","first-page":"3176","DOI":"10.3390\/cells10113176","article-title":"Role of AHR Ligands in Skin Homeostasis and Cutaneous Inflammation","volume":"10","author":"Fern\u00e1ndez-Gallego","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.ejps.2026.107510_bib0016","article-title":"A Comprehensive Review of Nanogel-Based Drug Delivery Systems","author":"Ferozekhan","year":"2024","journal-title":"Cureus"},{"key":"10.1016\/j.ejps.2026.107510_bib0017","doi-asserted-by":"crossref","first-page":"5424","DOI":"10.3390\/ijms20215424","article-title":"Aryl Hydrocarbon Receptor in Atopic Dermatitis and Psoriasis","volume":"20","author":"Furue","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejps.2026.107510_bib0018","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.122535","article-title":"Nanotechnology-based alternatives for the topical delivery of immunosuppressive agents in psoriasis","volume":"631","author":"Gomes","year":"2023","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2026.107510_bib0019","first-page":"279","author":"Hennen","year":"2017","journal-title":"Keratinocytes improve prediction of sensitization potential and potency of chemicals with THP-1 cells"},{"key":"10.1016\/j.ejps.2026.107510_bib0020","doi-asserted-by":"crossref","DOI":"10.1111\/aji.13249","article-title":"Cytokine mRNA and protein expression by cell cultures of epithelial ovarian cancer\u2014Methodological considerations on the choice of analytical method for cytokine analyses","volume":"84","author":"Israelsson","year":"2020","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.ejps.2026.107510_bib0021","article-title":"Treatment of chronic plaque psoriasis: An overview on current update","volume":"2","author":"Jurel","year":"2024","journal-title":"Pharmacol. Res. - Rep."},{"key":"10.1016\/j.ejps.2026.107510_bib0022","doi-asserted-by":"crossref","first-page":"5823","DOI":"10.1038\/s41598-019-42256-0","article-title":"Differentiating SGBS adipocytes respond to PPAR\u03b3 stimulation, irisin and BMP7 by functional browning and beige characteristics","volume":"9","author":"Klus\u00f3czki","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejps.2026.107510_bib0023","doi-asserted-by":"crossref","first-page":"560","DOI":"10.2174\/1389202921999200716103758","article-title":"Discrepant mRNA and Protein Expression in Immune Cells","volume":"21","author":"Li","year":"2020","journal-title":"Curr. Genomics"},{"key":"10.1016\/j.ejps.2026.107510_bib0024","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2025.117559","article-title":"Dual activation of AhR and Nrf2 pathways by the natural stilbenoid tapinarof protects against particulate matter-induced skin barrier dysfunction","volume":"505","author":"Lin","year":"2025","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.ejps.2026.107510_bib0025","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.18326","article-title":"Indigo alleviates psoriasis through the AhR\/NF-\u03baB signaling pathway: an in vitro and in vivo study","volume":"12","author":"Lin","year":"2024","journal-title":"PeerJ"},{"key":"10.1016\/j.ejps.2026.107510_bib0026","doi-asserted-by":"crossref","first-page":"9845","DOI":"10.3390\/ijms23179845","article-title":"An Update on Photodynamic Therapy of Psoriasis\u2014Current Strategies and Nanotechnology as a Future Perspective","volume":"23","author":"Makuch","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejps.2026.107510_bib0027","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2023.1232109","article-title":"Nanogels as novel drug nanocarriers for CNS drug delivery","volume":"10","author":"Manimaran","year":"2023","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.ejps.2026.107510_bib0028","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ejpb.2022.05.012","article-title":"Nanocarriers for the topical treatment of psoriasis - pathophysiology, conventional treatments, nanotechnology, regulatory and toxicology","volume":"176","author":"Mascarenhas-Melo","year":"2022","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejps.2026.107510_bib0029","doi-asserted-by":"crossref","DOI":"10.1111\/dth.15931","article-title":"Tapinarof for the treatment of psoriasis","volume":"35","author":"Nogueira","year":"2022","journal-title":"Dermatol. Ther."},{"key":"10.1016\/j.ejps.2026.107510_bib0030","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.jaad.2020.05.135","article-title":"Efficacy and patient-reported outcomes from a phase 2b, randomized clinical trial of tapinarof cream for the treatment of adolescents and adults with atopic dermatitis","volume":"84","author":"Paller","year":"2021","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.ejps.2026.107510_bib0031","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.3390\/biom10081111","article-title":"More Than Resveratrol: New Insights into Stilbene-Based Compounds","volume":"10","author":"Pecyna","year":"2020","journal-title":"Biomolecules"},{"key":"10.1016\/j.ejps.2026.107510_bib0032","doi-asserted-by":"crossref","first-page":"649","DOI":"10.3390\/pharmaceutics13050649","article-title":"Novel Self-Nano-Emulsifying Drug Delivery Systems Containing Astaxanthin for Topical Skin Delivery","volume":"13","author":"Ponto","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejps.2026.107510_bib0033","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1177\/0976500X221130851","article-title":"Tapinarof: A Felicitous Discovery in Psoriasis Treatment","volume":"13","author":"Prabath","year":"2022","journal-title":"J. Pharmacol. Pharmacother."},{"key":"10.1016\/j.ejps.2026.107510_bib0034","doi-asserted-by":"crossref","first-page":"13","DOI":"10.5530\/jyp.20251506","article-title":"Systematizing PDE4 Inhibition in Psoriasis Treatment: Roflumilast Leads the Way","volume":"17","author":"Ravindran","year":"2025","journal-title":"J. Young Pharm."},{"key":"10.1016\/j.ejps.2026.107510_bib0035","first-page":"689","article-title":"Resveratrol inhibits NF-kB signaling through suppression of p65 and l B kinase activites","author":"Rirong Yang","year":"2013","journal-title":"Pharmazie"},{"key":"10.1016\/j.ejps.2026.107510_bib0036","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.jaad.2018.10.037","article-title":"Phase 2, randomized dose-finding study of tapinarof (GSK2894512 cream) for the treatment of plaque psoriasis","volume":"80","author":"Robbins","year":"2019","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.ejps.2026.107510_bib0037","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106642","article-title":"Deucravacitinib is an allosteric TYK2 protein kinase inhibitor FDA-approved for the treatment of psoriasis","volume":"189","author":"Roskoski","year":"2023","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejps.2026.107510_bib0038","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1007\/s12016-024-08991-7","article-title":"The Immunology of Psoriasis\u2014Current Concepts in Pathogenesis","volume":"66","author":"Sieminska","year":"2024","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.ejps.2026.107510_bib0039","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaci.2023.12.013","article-title":"Tapinarof validates the aryl hydrocarbon receptor as a therapeutic target: A clinical review","volume":"154","author":"Silverberg","year":"2024","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.ejps.2026.107510_bib0040","article-title":"Breakthroughs and bottlenecks of psoriasis therapy: Emerging trends and advances in lipid based nano-drug delivery platforms for dermal and transdermal drug delivery","volume":"84","author":"Singh","year":"2023","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.ejps.2026.107510_bib0041","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1016\/j.jid.2017.05.004","article-title":"Tapinarof Is a Natural AhR Agonist that Resolves Skin Inflammation in Mice and Humans","volume":"137","author":"Smith","year":"2017","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.ejps.2026.107510_bib0042","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.jaad.2022.06.1171","article-title":"One-year safety and efficacy of tapinarof cream for the treatment of plaque psoriasis: Results from the PSOARING 3 trial","volume":"87","author":"Strober","year":"2022","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.ejps.2026.107510_bib0043","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2024.122991","article-title":"Advances in psoriasis research: From pathogenesis to therapeutics","volume":"355","author":"Sugumaran","year":"2024","journal-title":"Life Sci"},{"key":"10.1016\/j.ejps.2026.107510_bib0044","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2024.106846","article-title":"Development of Imiquimod-induced HaCaT-THP-1 co-culture for modeling of psoriasis","volume":"200","author":"V\u00e1radi","year":"2024","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2026.107510_bib0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.eurpolymj.2023.112630","article-title":"Advances in hydrogels based cutaneous drug delivery system for management of psoriasis","volume":"202","author":"Vasowala","year":"2024","journal-title":"Eur. Polym. J."},{"key":"10.1016\/j.ejps.2026.107510_bib0046","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/nrg3185","article-title":"Insights into the regulation of protein abundance from proteomic and transcriptomic analyses","volume":"13","author":"Vogel","year":"2012","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.ejps.2026.107510_sbref0047","article-title":"The treatment of psoriasis via herbal formulation and nanopolyherbal formulation: A new approach","volume":"15","author":"Yadav","year":"2024","journal-title":"BioImpacts"},{"key":"10.1016\/j.ejps.2026.107510_bib0048","doi-asserted-by":"crossref","first-page":"13860","DOI":"10.1002\/ece3.6976","article-title":"Relationships between immune gene expression and circulating cytokine levels in wild house mice","volume":"10","author":"Young","year":"2020","journal-title":"Ecol. Evol."},{"key":"10.1016\/j.ejps.2026.107510_bib0049","doi-asserted-by":"crossref","first-page":"e137","DOI":"10.1016\/j.jaad.2021.10.053","article-title":"A novel topical treatment for plaque psoriasis: Benvitimod\/tapinarof","volume":"86","author":"Zhang","year":"2022","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.ejps.2026.107510_bib0051","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1097\/CM9.0000000000003260","article-title":"Tapinarof inhibits psoriatic inflammation through inducing tolerogenic dendritic cells and Foxp3+ Tregs","volume":"137","author":"Zhao","year":"2024","journal-title":"Chin. Med. J. (Engl.)"},{"key":"10.1016\/j.ejps.2026.107510_bib0052","doi-asserted-by":"crossref","first-page":"460","DOI":"10.5114\/ada.2021.108445","article-title":"Treatments in psoriasis: from standard pharmacotherapyto nanotechnology therapy","volume":"39","author":"Zhu","year":"2022","journal-title":"Adv. Dermatol. Allergol."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098726000849?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098726000849?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T11:53:01Z","timestamp":1779709981000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098726000849"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":51,"alternative-id":["S0928098726000849"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2026.107510","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In Vitro Investigation of Tapinarof-Loaded Nanogels in an Imiquimod-induced HaCaT\u2013THP-1 Co-Culture Model","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2026.107510","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"107510"}}